LITTLETON, Mass. & MILWAUKEE--(BUSINESS WIRE)--Mevion Medical Systems, a leading provider of proton therapy solutions, today announced the successful delivery of its MEVION S250i Proton Therapy System® to the Medical College of Wisconsin (MCW) Cancer Center at Froedtert Hospital. This milestone marks a significant advancement in cancer care for patients in Wisconsin, providing access to a highly targeted and effective treatment option..

马萨诸塞州利特尔顿和密尔沃基--（商业新闻短讯）--质子治疗解决方案的领先供应商Mevion Medical Systems今天宣布，其Mevion S250i质子治疗系统®成功交付给弗罗德特医院威斯康星州医学院（MCW）癌症中心。这一里程碑标志着威斯康星州癌症护理取得了重大进展，为患者提供了高度针对性和有效的治疗选择。。

First Compact Proton Therapy System in Wisconsin

威斯康星州首套紧凑型质子治疗系统

Unlike traditional radiation therapy, proton therapy uses a unique characteristic of protons—their ability to deposit most of their energy at a specific depth—to target tumors with exceptional accuracy. The MEVION S250i is the first compact proton therapy system to be installed in Wisconsin, making MCW a leader in providing this innovative technology to patients in the region..

与传统的放射疗法不同，质子疗法利用质子的独特特性，即质子能够将大部分能量沉积在特定深度，以极高的准确性靶向肿瘤。MEVION S250i是威斯康星州安装的第一个紧凑型质子治疗系统，使MCW成为该地区为患者提供这种创新技术的领导者。。

Unique Elevated Vault Installation

独特的高架拱顶安装

In another first, the MEVION S250i is installed in an elevated vault, a unique design that places it on the same level as the existing radiation oncology clinical space on the 3rd floor of the cancer center. This innovative approach streamlines patient flow and enhances operational efficiency. The MEVION S250i is the most compact proton therapy system in the world, with all necessary equipment housed within a single vault.

在另一个首次中，MEVION S250i安装在高架拱顶中，这是一种独特的设计，将其与癌症中心三楼现有的放射肿瘤学临床空间置于同一水平。这种创新的方法简化了患者流程并提高了运营效率。MEVION S250i是世界上最紧凑的质子治疗系统，所有必要的设备都位于一个拱顶内。

This compact design allows for greater flexibility in installation, making proton therapy accessible to more hospitals and clinics..

这种紧凑的设计允许更大的安装灵活性，使更多的医院和诊所可以使用质子治疗。。

Advanced Technology for Improved Patient Outcomes

先进技术改善患者预后

The MEVION S250i is a compact and versatile proton therapy system designed to deliver precise radiation treatment to tumors while minimizing damage to healthy tissues. With its advanced technology and streamlined workflow, the system offers a range of benefits for patients, including reduced treatment time and improved quality of life..

MEVION S250i是一种紧凑而通用的质子治疗系统，旨在为肿瘤提供精确的放射治疗，同时最大程度地减少对健康组织的损害。凭借其先进的技术和简化的工作流程，该系统为患者提供了一系列好处，包括缩短治疗时间和提高生活质量。。

'We are thrilled to partner with the Medical College of Wisconsin to bring this cutting-edge technology to the region,' said Tina Yu, PhD, CEO and President at Mevion Medical Systems. 'The MEVION S250i will provide patients with access to the most advanced cancer care available, and we look forward to seeing the positive impact it will have on the community.'.

Mevion Medical Systems首席执行官兼总裁Tina Yu博士说，我们很高兴与威斯康星医学院合作，将这项尖端技术带到该地区MEVION S250i将为患者提供最先进的癌症护理，我们期待看到它对社区产生积极影响。”。

'Proton therapy represents a significant advancement in cancer care, offering patients a highly precise and targeted treatment option,' said Christopher Schultz, MD, FACR, MCW professor and chairman of the Department of Radiation Oncology. 'By delivering radiation directly to the tumor while minimizing damage to surrounding healthy tissue, we can improve outcomes, reduce side effects, and enhance the overall quality of life for our patients.'.

医学博士、FACR、MCW教授、放射肿瘤学系主任克里斯托弗·舒尔茨（ChristopherSchultz）说：“质子疗法代表了癌症护理的重大进步，为患者提供了高度精确和有针对性的治疗选择。”通过直接向肿瘤提供辐射，同时最大限度地减少对周围健康组织的损害，我们可以改善预后，减少副作用，并提高患者的整体生活质量。”。

About Mevion Medical Systems

关于Mevion Medical Systems

Mevion Medical Systems is the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy. Since 2013, Mevion compact proton therapy single-room systems have been used by leading cancer centers for treating patients.

Mevion Medical Systems是用于癌症护理的紧凑型质子治疗系统的领先供应商。Mevion致力于推进全球质子治疗的设计和可访问性，开创了单室平台，并继续推进质子治疗的科学和应用。自2013年以来，Mevion compact质子治疗单室系统已被领先的癌症中心用于治疗患者。

Mevion’s series of products, including the flagship MEVION S250i and MEVION S250-FIT* with HYPERSCAN pencil beam scanning, represent the world’s most compact proton therapy systems that eliminate the obstacles of size, complexity, and cost. Mevion is headquartered in Littleton, Massachusetts with a presence in Europe and Asia.

Mevion的系列产品，包括旗舰产品Mevion S250i和带有HYPERSCAN铅笔束扫描的Mevion S250-FIT*，代表了世界上最紧凑的质子治疗系统，消除了尺寸、复杂性和成本方面的障碍。Mevion总部位于马萨诸塞州的利特尔顿，在欧洲和亚洲都有业务。

For more information, please visit www.mevion.com..

有关更多信息，请访问www.mevion.com。。

About Medical College of Wisconsin Froedtert

关于威斯康星医学院Froedtert

The Froedtert & the Medical College of Wisconsin regional health network is a partnership between Froedtert Health and the Medical College of Wisconsin, supporting a shared mission of patient care, innovation, medical research and education. Our health network operates eastern Wisconsin's only academic medical center and adult Level I Trauma Center at Froedtert Hospital, Milwaukee, an internationally recognized training and research center engaged in thousands of clinical trials and studies.

Froedtert&威斯康星州医学院区域卫生网络是Froedtert health和威斯康星州医学院之间的合作伙伴，支持患者护理、创新、医学研究和教育的共同使命。我们的健康网络在密尔沃基Froedtert医院运营着威斯康星州东部唯一的学术医疗中心和成人I级创伤中心，这是一家国际公认的培训和研究中心，从事数千项临床试验和研究。

The Froedtert & MCW Health Network, which includes nine hospital locations, more than 2,000 physicians and more than 45 health centers and clinics, draws patients from throughout the Midwest and the nation. In our most recent fiscal year, outpatient visits were nearly 1.5 million, inpatient admissions to our hospitals were 55,085, and visits to our network physicians exceeded 1.1 million.

Froedtert＆MCW健康网络包括9个医院地点，2000多名医生以及45多个健康中心和诊所，吸引了来自中西部和全国的患者。在我们最近的一个财政年度，门诊就诊人数接近150万，我们医院的住院人数为55085人，我们网络医生的就诊人数超过110万。

Learn more about the Froedtert & MCW Health Network..

了解有关Froedtert＆MCW健康网络的更多信息。。

*The MEVION S250-FIT Proton Therapy System is not yet available for clinical use.

*MEVION S250-FIT质子治疗系统尚未用于临床。